Nature Cardiovascular Research, published by SpringerNature in Germany, stands as a premier journal dedicated to advancing the field of cardiovascular sciences. With an impressive 2023 categorization in the Q1 quartile across multiple disciplines—including Biochemistry, Genetics and Molecular Biology, Cardiology, and Medicine—this journal uniquely positions itself as a leading resource for pioneering research and innovative findings. Although currently not open access, it provides a rich repository of peer-reviewed articles that contribute directly to the evolving landscape of cardiovascular medicine. The journal aims to bridge the knowledge gap between basic science and clinical application, catering to researchers, healthcare professionals, and students alike who are immersed in the complexities of cardiovascular health. With robust Scopus rankings in key categories, Nature Cardiovascular Research is poised to shape future directions in the field, helping to foster a deeper understanding of cardiovascular diseases and their underlying mechanisms. Explore the latest research and be part of the conversation in one of the most impactful scientific domains.

The International Journal of Vascular Medicine is a peer-reviewed, open access journal dedicated to advancing research and knowledge in the field of vascular medicine. Published by HINDAWI LTD and operating since 2010, this journal provides a platform for the dissemination of high-quality studies, reviews, and case reports related to cardiovascular health. Based in Egypt, the journal's comprehensive scope encompasses a range of topics within cardiology and cardiovascular medicine, with a current impact factor reflected by its Q3 ranking in 2023, positioning it among the noteworthy publications in its category. With a Scopus rank of 176 out of 387, the journal maintains a significant presence in the academic community, supported by a commitment to open access, ensuring that research is freely available to all stakeholders. Researchers, professionals, and students alike are encouraged to contribute to and engage with the International Journal of Vascular Medicine as it enhances the understanding and treatment of vascular diseases and promotes innovative practices within the field.

Clinical Medicine Insights-Cardiology is a prestigious open-access journal published by SAGE Publications Ltd, focusing on cutting-edge research in the field of cardiology and cardiovascular medicine. With the ever-evolving landscape of cardiovascular health, this journal serves as a vital platform for disseminating significant findings, clinical practices, and innovative therapies. Established in 2007, it has rapidly gained recognition, currently ranked in the Q2 category for cardiology, positioned at #112 out of 387 in Scopus Rankings, and boasting a commendable 71st percentile. The journal not only emphasizes the integration of recent advancements in clinical and laboratory studies but also aims to bridge the gap between research and practice, making it an essential resource for researchers, healthcare professionals, and students alike. Situated in New Zealand and operating with an open-access model, Clinical Medicine Insights-Cardiology promotes the unrestricted dissemination of knowledge, ensuring that critical insights into cardiovascular medicine are accessible globally.

COR ET VASA is a prominent peer-reviewed journal in the field of cardiology and cardiovascular medicine, published by the Czech Society of Cardiology and Czech Society of Cardiovascular Surgery. Established in 1961, and continuing its legacy from 2006 to 2024, this journal serves as an essential platform for disseminating significant research findings, clinical studies, and innovative treatments in cardiovascular health. While currently positioned in the Q4 quartile, the journal aims to enhance its impact by fostering knowledge sharing among researchers, clinicians, and students alike. The journal, with its publication in Czech Republic, provides a unique perspective to the European cardiovascular community, allowing for invaluable insights and discourse. Researchers are encouraged to submit their manuscripts and contribute to the growing body of knowledge in this critical area, although it should be noted that COR ET VASA does not offer open access options at this time. As the field of cardiovascular medicine evolves, COR ET VASA remains committed to addressing the latest challenges and advancements, nurturing a rich dialogue within the community.

BMC Cardiovascular Disorders is a premier open access journal dedicated to the field of cardiology and cardiovascular medicine, published by BMC, a leading publisher in the scientific community. Since its inception in 2001, this journal has provided a platform for high-quality research, showcasing innovative studies and critical reviews that contribute to the understanding and management of cardiovascular diseases. With an impressive impact factor and a rank in the Q2 category for 2023 within its field, BMC Cardiovascular Disorders stands at the forefront of cardiovascular research, enabling accessibility to a wealth of information that fosters collaboration and advancements in patient care. The journal's commitment to open access ensures that research is widely disseminated and easily accessible to researchers, practitioners, and students globally, enhancing the dialogue around cardiovascular health and disease prevention. Located in the United Kingdom, BMC Cardiovascular Disorders consistently aims to promote excellence in the study and treatment of cardiovascular conditions, encouraging the exchange of knowledge that ultimately benefits public health.

Artery Research is an esteemed open access journal published by BMC in the United Kingdom, dedicated to advancing the field of vascular biology and cardiovascular medicine. Since its inception in 2006 and transitioning to an open access format in 2019, the journal has become a pivotal platform for disseminating high-quality research on arterial health, pathology, and the latest clinical advancements. With an impactful focus on anatomy, cardiology, and physiology, Artery Research holds a notable reputation within the global research community, ranked in the Q3 and Q4 category quartiles in its respective fields and reflected in its Scopus ranks. The journal aims to foster collaborations and discussions among researchers and practitioners by providing an accessible avenue for publishing pivotal findings and insights. As it continues to evolve through 2024 and beyond, Artery Research remains committed to enriching cardiovascular research and driving innovations toward better health outcomes.

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

Vascular Health and Risk Management is a leading peer-reviewed journal published by DOVE MEDICAL PRESS LTD, focusing on the critical areas of cardiology, endocrinology, and public health. With an impact factor that reflects its significance within the scientific community, this Open Access journal, established in 2005, has been committed to enhancing knowledge on the interplay between vascular health and various risk factors affecting patient outcomes. The journal is proudly based in New Zealand and is indexed across multiple categories, maintaining a prominent Q2 ranking in cardiology, endocrinology, diabetes, and several other medical disciplines as of 2023. By providing a platform for innovative research and comprehensive reviews, Vascular Health and Risk Management seeks to foster collaboration among healthcare professionals, enhance clinical practices, and ultimately improve patient care through rigorous scientific inquiry and disseminated knowledge. Researchers, professionals, and students will find invaluable insights that inform their work and advance the understanding of vascular-related health issues.

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.